Brachystemma calycinum D. Don Effectively Reduces the Locomotor Disability in Dogs with Naturally Occurring Osteoarthritis: A Randomized Placebo-Controlled Trial
Figure 4
Temporal evolution of the locomotor activity recording over a 6-week period (42 days) in dogs receiving either treatment with Brachystemma calycinum D. Don (BCD) or a placebo. Data are the daily duration of active period and are expressed as mean (standard deviation). Periods were baseline (day −5 to day 0, not shown), first period (day 17 to day 21), and the second period (day 38 to day 42). At the second period, BCD-treated dogs had significantly higher daily duration of active period () when compared to baseline.
